FI762053A7 - - Google Patents

Download PDF

Info

Publication number
FI762053A7
FI762053A7 FI762053A FI762053A FI762053A7 FI 762053 A7 FI762053 A7 FI 762053A7 FI 762053 A FI762053 A FI 762053A FI 762053 A FI762053 A FI 762053A FI 762053 A7 FI762053 A7 FI 762053A7
Authority
FI
Finland
Application number
FI762053A
Other languages
Finnish (fi)
Inventor
George Madison Sieger
James Elwood Krueger
Arnold Curtis Osterberg
David Henry Tedeschi
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI762053A7 publication Critical patent/FI762053A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI762053A 1975-07-16 1976-07-15 FI762053A7 (Direct)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/596,488 US4016273A (en) 1975-07-16 1975-07-16 Sustained release forms of certain oxazepines for parenteral administration

Publications (1)

Publication Number Publication Date
FI762053A7 true FI762053A7 (Direct) 1977-01-17

Family

ID=24387483

Family Applications (1)

Application Number Title Priority Date Filing Date
FI762053A FI762053A7 (Direct) 1975-07-16 1976-07-15

Country Status (11)

Country Link
US (1) US4016273A (Direct)
BE (1) BE844203A (Direct)
CA (1) CA1062159A (Direct)
DE (1) DE2630394A1 (Direct)
DK (1) DK319776A (Direct)
FI (1) FI762053A7 (Direct)
FR (1) FR2317912A1 (Direct)
GB (1) GB1525425A (Direct)
NL (1) NL7607918A (Direct)
PT (1) PT65358B (Direct)
SE (1) SE7608114L (Direct)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617321B2 (en) 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US6199634B1 (en) 1998-08-27 2001-03-13 Viatchelav Ivanovich Selyakov Method and apparatus for controlling the permeability of mineral bearing earth formations
ES2253375T3 (es) * 2000-04-19 2006-06-01 Genentech, Inc. Formulaciones de liberacion sostenida.
WO2002013870A2 (en) * 2000-08-17 2002-02-21 Mitokor, Inc. Formulation for administering therapeutic lipophilic molecules
DE10059020A1 (de) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Parenteral applizierbare Darreichungsformen
PT1397155E (pt) * 2001-06-21 2015-12-07 Genentech Inc Formulação de libertação sustentada
US6972195B2 (en) * 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
KR20070006708A (ko) * 2004-01-07 2007-01-11 트라이머리스 인코퍼레이티드 ＨＩＶ ｇｐ41 ＨＲ2-유래된 합성 펩티드 및 인간 면역결핍바이러스의 전염을 저해하는 치료에서 이들의 용도
WO2006073886A1 (en) * 2005-01-05 2006-07-13 Eli Lilly And Company Olanzapine pamoate dihydrate
CN101415723B (zh) * 2006-02-02 2014-06-25 特里梅里斯公司 具有改良生物学特性的hiv融合抑制肽
EP1884507B1 (de) * 2006-07-27 2010-05-12 Cognis IP Management GmbH Verfahren zur Herstellung von Glycerin
EP2139526A4 (en) * 2007-04-03 2010-07-14 Trimeris Inc NEW FORMULATIONS TO RELEASE ANTIVIRAL PEPTIDE THERAPEUTICS
CA2700354A1 (en) * 2007-09-25 2009-04-02 Trimeris, Inc. Novel methods of synthesis for therapeutic antiviral peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3164520A (en) * 1962-10-29 1965-01-05 Olin Mathieson Injectable steroid compositions containing at least 75% benzyl benzoate
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3546220A (en) * 1966-08-01 1970-12-08 Abbott Lab 2,3-dihydro-1h-pyrido-(2,3-b)(1,4)thiazines
US3549621A (en) * 1968-04-29 1970-12-22 Harry Louis Yale 12-substituted-6h-dibenz(b,f)(1,4)oxazocin-11(12h) ones
US3891647A (en) * 1970-08-06 1975-06-24 Wander Ag Dr A 2-trifluoromethyl-sulphonyl-11-substituted-piperazinyl-dibenz {8 b,f{9 {8 1,4{9 {0 oxazepine
US3773768A (en) * 1970-10-26 1973-11-20 American Cyanamid Co 7-amino-2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine and salts thereof

Also Published As

Publication number Publication date
CA1062159A (en) 1979-09-11
GB1525425A (en) 1978-09-20
US4016273A (en) 1977-04-05
SE7608114L (sv) 1977-01-17
BE844203A (fr) 1977-01-17
FR2317912A1 (fr) 1977-02-11
PT65358B (en) 1978-01-09
DE2630394A1 (de) 1977-02-03
DK319776A (da) 1977-01-17
FR2317912B1 (Direct) 1979-04-13
PT65358A (en) 1976-08-01
NL7607918A (nl) 1977-01-18

Similar Documents

Publication Publication Date Title
IN144685B (Direct)
FR2317912B1 (Direct)
JPS5215860U (Direct)
JPS525520U (Direct)
JPS51146132U (Direct)
AU496568B2 (Direct)
JPS541063Y2 (Direct)
JPS539520Y2 (Direct)
CS173527B1 (Direct)
CS174719B1 (Direct)
JPS51111592U (Direct)
JPS51126452U (Direct)
CS173393B1 (Direct)
JPS5251196U (Direct)
JPS5237120U (Direct)
JPS5277269U (Direct)
JPS51147781U (Direct)
JPS51155152U (Direct)
CH589168B5 (Direct)
CH866275A4 (Direct)
BG26417A1 (Direct)
CH586966A5 (Direct)
CH603736A5 (Direct)
BG23310A1 (Direct)
CH589226A5 (Direct)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: AMERICAN CYANAMID COMPANY